Safety of Intranasal Ketamine for Reducing Uncontrolled Cancer-Related Pain: Protocol of a Phase I/II Clinical Trial

BACKGROUND: Approximately 12 million Americans are affected with cancer. Of these, 53% experience pain at all stages of cancer. Pain may remain uncontrolled despite high-dose opioid therapy, and opioids have many well-documented harmful side effects. Intranasal ketamine has been shown to be effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Shteamer, Jack W, Harvey, R Donald, Spektor, Boris, Curseen, Kimberly, Egan, Katherine, Chen, Zhengjia, Gillespie, Theresa W, Sniecinski, Roman M, Singh, Vinita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2019
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658277/
https://www.ncbi.nlm.nih.gov/pubmed/31038469
http://dx.doi.org/10.2196/12125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658277/
https://www.ncbi.nlm.nih.gov/pubmed/31038469
http://dx.doi.org/10.2196/12125

Ejemplares similares